Ginlix AI
50% OFF

Comparison Analysis of UBTECH's Humanoid Robot Commercialization Progress vs. Market Expectations

#humanoid_robot #commercialization #market_expectation #ubi_robotics #industrial_robotics #robotics_industry #earnings_analysis
Mixed
A-Share
December 31, 2025

Unlock More Features

Login to access AI-powered analysis, deep research reports and more advanced features

Comparison Analysis of UBTECH's Humanoid Robot Commercialization Progress vs. Market Expectations

About us: Ginlix AI is the AI Investment Copilot powered by real data, bridging advanced AI with professional financial databases to provide verifiable, truth-based answers. Please use the chat box below to ask any financial question.

Related Stocks

09880
--
09880
--

Based on the latest information I have collected, I will provide you with a detailed analysis of the comparison between UBTECH’s humanoid robot commercialization progress and market expectations.

Analysis of UBTECH’s Humanoid Robot Commercialization Progress vs. Market Expectations
I. Actual Commercialization Progress
1.
2024 Commercial Performance (Below Expectations)

According to UBTECH’s 2024 financial report data [1]:

  • Humanoid robot deliveries
    : Only 10 units delivered throughout the year, which is in stark contrast to the market’s previous high expectations
  • Financial performance
    : Annual loss of RMB 1.16 billion, cumulative loss exceeding RMB 5 billion since 2020
  • Revenue structure
    : Consumer robot revenue was RMB 477 million (year-on-year increase of 88.1%), accounting for 36.5% of total revenue, becoming the largest revenue source for the first time, but with low gross profit margin
2.
2025 Commercial Progress (Significant Improvement)

UBTECH’s recently disclosed 2025 data shows [2][3]:

  • Order status
    : 2025 full-year orders have reached nearly
    RMB 1.4 billion
  • Deliveries
    : Industrial humanoid robot Walker S2 delivered over
    500 units
    throughout the year
  • Production capacity scale
    : Liuzhou Robot Super Smart Factory with a capacity of over 1,000 units is about to be fully put into operation
  • Capacity expansion plan
    : Target capacity will reach
    10,000 units
    by 2026
  • Strategic layout
    : Plans to acquire 43% equity of Fenglong Shares for RMB 1.665 billion to improve industrial chain layout
II. Comparative Analysis of Market Expectations
1.
2024 Expectation Gap is Significant

High Market Expectations vs. Real Difficulties:

  • As the “first Chinese humanoid robot stock”, the market had high expectations for UBTECH’s commercial prospects in the early days of its listing
  • However, the reality of only delivering 10 units in 2024 is in sharp contrast to the overall industry enthusiasm
  • Well-known investor Zhu Xiaohu publicly stated that he has withdrawn from the humanoid robot track in batches, questioning its commercial prospects [1]
2.
2025 Performance Exceeds Expectations

Key Indicators Show Significant Improvement:

Indicator 2024 2025 Growth Rate
Humanoid robot deliveries 10 units 500+ units
50x
Full-year order value - RMB1.4 billion Significant breakthrough
Production capacity scale - 1,000 units Capacity ramp-up
3.
Analyst Expectation Adjustments

Citibank’s Latest Views:

  • Raised UBTECH’s target price from HK$98 to
    HK$121
    [4]
  • Upgraded the company’s revenue forecasts for this year and next by 2% and 13% respectively
  • Based on a one-year forecast price-to-sales ratio of 21x, reflecting expectations for the humanoid robot business
  • Believes the company’s commercialization process is accelerating
III. Competitive Landscape and Market Positioning
1.
Price Competition Pressure

UBTECH faces fierce price competition [1]:

  • Unitree Robotics
    : The G1 robot is sold for only RMB99,000, taking a low-price route
  • UBTECH Walker Series
    : Over RMB1 million per unit
  • New Product Strategy
    : Launched “Tiangong Walker” priced at RMB299,000 in 2024, attempting to penetrate the lower-end market
2.
Changes in Market Share

The pattern of China’s humanoid robot market gradually became clear in 2025 [1][5]:

  • Leading Enterprises
    : Huawei, Unitree, DeepRobotics, Xiaomi, etc., have become major players
  • UBTECH’s Positioning
    : Maintains technological leadership in industrial applications, faces challenges in the consumer market
  • Morgan Stanley’s Expectation
    : By 2050, China’s robot market size will reach US$4.7 trillion (a 100x growth) [5]
IV. Conclusion: Does Commercialization Meet Market Expectations?
Comprehensive Assessment: In Line with an Exceeding-Expectation Development Trajectory
  1. Short-term (2024): Significantly Below Market Expectations

    • Only delivered 10 humanoid robots, exposing major obstacles in the commercialization process
    • Sustained losses and funding pressure raised market doubts about the business model
  2. Mid-term (2025): Significantly Exceeds Market Expectations

    • Order value of nearly RMB1.4 billion and deliveries of 500 units, achieving a 50x growth
    • Rapid capacity expansion shows improved manufacturing capabilities
    • Industrial chain integration strategy (acquisition of Fenglong Shares) enhances competitiveness
  3. Long-term: In Line with Industry Development Laws

    • The humanoid robot industry is generally in the early stage from technology verification to commercialization
    • Morgan Stanley predicts the industry will grow 100x, and UBTECH is expected to benefit from this
    • The characteristics of high technical thresholds and long payback periods require continuous capital investment
V. Risks and Opportunities
Key Risks:
  • Sustained funding pressure (conducted 4 rights issues in 2024, raising over HK$2 billion) [1]
  • Accounts receivable risk (total of RMB1.31 billion, increasing bad debt risk) [1]
  • Fierce price competition (insufficient cost performance compared to Unitree Robotics)
Development Opportunities:
  • Huge market size (Morgan Stanley predicts a US$4.7 trillion market) [5]
  • Strong demand in industrial application scenarios (manufacturing, logistics, quality inspection, etc.) [5]
  • Technological leadership advantage (Walker series maintains competitiveness in the industrial humanoid robot field)

References

[1] Is the humanoid robot industry in a cold winter? UBTECH loses RMB1.16 billion annually and only delivers 10 robots - Yahoo Hong Kong Finance (https://hk.finance.yahoo.com/news/人形機器人產業陷寒冬-優必選年虧11-6億僅交付10台機器人-083553463.html)

[2] UBTECH (09880.HK) Chairman Zhou Jian voluntarily禁售 shares for 12 months - Yahoo Hong Kong Finance (https://hk.finance.yahoo.com/news/優必選-09880-hk-主席周劍自願12個月內禁售持股-011536082.html)

[3] UBTECH (09880.HK) rises over 2% as chairman promises to禁售 shares for 12 months - Yahoo Hong Kong Finance (https://hk.finance.yahoo.com/news/優必選-09880-hk-升逾2-主席承諾12個月内禁售持股-015336281.html)

[4] 《Dahang》 Citibank raises UBTECH (09880.HK) target price to HK$121 based on the company - Yahoo Hong Kong Finance (https://hk.finance.yahoo.com/news/大行-花旗上調優必選-09880-hk-目標價至121元-091326723.html)

[5] Morgan Stanley: China’s humanoid robot market will grow 100x to US$4.7 trillion - Yahoo Hong Kong Finance (https://hk.finance.yahoo.com/news/大摩-中國人形機器人市場將增100倍至4-7兆-065005697.html)

Ask based on this news for deep analysis...
Alpha Deep Research
Auto Accept Plan

Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.